America’s confused response to increased global competition and IP uncertainty is threatening its innovation leadership
Register to access two of our subscriber only articles per month.
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
@IAM_Alerts This week’s IAM Sunday Supplement is now out, including: Top EPO and PCT IP firms named; Ups and downs of licensing… https://t.co/hBRrT0tWho Read more
@IAM_Alerts In their drive towards specialisation, Big Pharma companies risk neglecting many potentially valuable IP assets. A… https://t.co/xT99Wb3ga2 Read more
@IAM_Alerts After duking it out with NPEs and others at the PTAB for the last few years, @unifiedpatents has launched a new ven… https://t.co/R7XMZKKOJz Read more
@IAM_Alerts Chinese IP firm named as top PCT representative for 2020 https://t.co/2g7B6fVTuF https://t.co/mrF0ZOTeVn Read more